Jan 10, 2024
Freyr SUBMIT Pro is one of the best eCTD software tool which helps Life science companies in various regulatory submissions to global health Authorities.
seen from United States
seen from Egypt
seen from United States
seen from Venezuela
seen from Sweden
seen from Russia
seen from United States
seen from Singapore
seen from United Kingdom
seen from Sweden
seen from Türkiye
seen from Netherlands
seen from Slovakia
seen from United States
seen from Australia
seen from China
seen from United States
seen from Singapore
seen from Netherlands
seen from United States
Freyr SUBMIT Pro is one of the best eCTD software tool which helps Life science companies in various regulatory submissions to global health Authorities.
Best eCTD Software Tool for global eCTD Submissions
Free WordPress Theme
Free WordPress Theme
An Investigational New Drug (IND) sponsored by a corporate entity is considered as a ‘Commercial IND.’ Center for Drug Evaluation and Research (CDER) has the authorization to designate IND as commercial if it finds the intent to commercialize the drug in future. In the United States, INDs must be registered with the Food and Drug Administration (FDA). As part of the implementation of FDA’s final notification released on May 5th, 2015 regarding adaption of eCTD formats, Commercial INDs are required to be submitted in eCTD format by May 5, 2018.
An Investigational New Drug (IND) sponsored by a corporate entity is considered as a ‘Commercial IND.’ Center for Drug Evaluation and Research (CDER) has the authorization to designate IND as commercial if it finds the intent to commercialize the drug in future. In the United States, INDs must be registered with the Food and Drug Administration (FDA). As part of the implementation of FDA’s final notification released on May 5th, 2015 regarding adaption of eCTD formats, Commercial INDs are required to be submitted in eCTD format by May 5, 2018.